Abstract P1-08-06: Low Tumor CD68 Mrna Content (intratumoral Macrophages) is Predictive for Benefit from Adjuvant Trastuzumab in HER2-positive Breast Cancer: an Analysis of the FinHER Trial
Cancer research（2013）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要